Trading the selloff: 8 stocks to buy

Don’t abandon biotech after it helped send U.S. markets reeling on Wednesday, CNBC “Fast Money” traders said.

“I’m still a believer in biotech,” said trader Guy Adami.

The Nasdaq (NASDAQ: .IXIC) was the biggest loser in Wednesday’s broad selloff, shedding more than 2 percent. The iShares Nasdaq Biotechnology ETF (NASDAQ: IBB) dropped more than 4 percent to close around $ 341.

Read More Stocks ripped as bad news looking bad

The fund has seen one-day moves of that magnitude in the past, so selling it now would be rash, Adami said. He added that Celgene (NASDAQ: CELG) looked appealing after slipping more than 4 percent to settle around $ 117 per share.

Amgen (NASDAQ: AMGN) seemed the most “defensive” biotech name despite falling more than 3 percent on Wednesday, trader Tim Seymour said. He noted that the stock has been “trapped” in a range near $ 160 per share for months.

Traders also discussed how to play other sectors hit hard in Wednesday’s selloff.


A more than 3 percent jump in U.S. crude oil prices (New York Mercantile Exchange: @CL.1) helped to push Dow transportation stocks (Dow Jones Global Indexes: .DJT) 2 percent lower on Wednesday. Delivery services company FedEx (NYSE: FDX) also fell more than 2 percent.

Read More There’s a huge sentiment split building in market

Weakness in the stock offers a buying opportunity, Seymour said. It closed around $ 165 per share on Wednesday.

Trader Brian Kelly looked at more direct energy plays. He liked movement in the Energy Select Sector SPDR Fund (NYSE Arca: XLE) and United States Brent Oil Fund (NYSE Arca: BNO), both of which climbed more than 1 percent higher on Wednesday.


Big-name chipmakers Qualcomm (NASDAQ: QCOM), Intel (NASDAQ: INTC) and Micron (NASDAQ: MU) all lost ground on Wednesday. Intel has the most upside in the space, Seymour and Kelly contended.

It dropped nearly 3 percent on Wednesday to close below $ 30 per share. Seymour noted that weakness in the personal computer business-which Intel heavily supplies-has already been priced in.

More From CNBC

  • News Page
  • Blogs Page
  • Earnings Central

You may also like...

Rules of Discussion on Trading the selloff: 8 stocks to buy

1. This forum is for discussion of financial markets. Please respect others view even if they are contrary to you.
2. Member's comments should lead to value addition in forum discussion.
3. If anyone is found making repetitive Explicit/Abusive/Racial comments, his account shall be banned and old posts will be deleted.
4. Providing Advice/Recommendations/Tips is fine but it should be free. Members cannot ask to be paid for it. Paid Advice is strictly prohibited
5. Spam links are not allowed. Too much promotion or using Contact info in ID will lead to account ban.
IMP : Members are requested to flag any violations to keep Forum Clean.
Loading comments …